Published in J Immunol on June 15, 1994
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy. J Exp Med (1997) 1.33
B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J Virol (2000) 1.30
Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J Clin Invest (1997) 1.27
A cell type-specific enhancer in the human B7.1 gene regulated by NF-kappaB. J Exp Med (1996) 1.11
CD28, CTLA-4 and their ligands: who does what and to whom? Immunology (2000) 1.10
Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem (2005) 1.09
Bovine CD4(+) T-lymphocyte clones specific for rhoptry-associated protein 1 of Babesia bigemina stimulate enhanced immunoglobulin G1 (IgG1) and IgG2 synthesis. Infect Immun (1999) 1.02
B effector cells in rheumatoid arthritis and experimental arthritis. Autoimmunity (2012) 0.95
Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. J Clin Invest (1997) 0.91
Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation. Immunology (1997) 0.91
Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect Immun (2003) 0.89
Antigen-presenting cell engineering. The molecular toolbox. Am J Pathol (1996) 0.81
Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen dose. Immunology (2000) 0.80
Targeting co-stimulatory pathways in gene therapy. Front Microbiol (2011) 0.80
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes. J Immunol (2012) 0.78
In vivo function of an interleukin 2 receptor beta chain (IL-2Rbeta)/IL-4Ralpha cytokine receptor chimera potentiates allergic airway disease. J Exp Med (1998) 0.78
Influence of MHC class I molecules on T-cell proliferation induced by CD3 or Thy-1 stimulation. Immunology (1995) 0.76
B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity (2000) 15.44
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90
Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol (1983) 14.36
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
CD28/B7 system of T cell costimulation. Annu Rev Immunol (1996) 10.48
IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Immunol (1980) 10.30
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
The B7 and CD28 receptor families. Immunol Today (1994) 6.38
Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol (1988) 5.80
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36
Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol (2001) 4.99
CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med (1996) 4.97
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (1989) 4.96
Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science (1993) 4.45
Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J Immunol (1989) 3.78
Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol (1991) 3.44
A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J Exp Med (1992) 3.37
CTLA-4: a negative regulator of autoimmune disease. J Exp Med (1996) 3.25
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A (1997) 3.25
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med (1995) 3.18
Suppressor T cells--they're back and critical for regulation of autoimmunity! Immunol Rev (2001) 3.16
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med (1991) 3.08
Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J Immunol (1995) 3.06
Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev (1982) 3.06
Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (1990) 3.02
Molecular basis of T cell inactivation by CTLA-4. Science (1998) 3.00
Alloreactive cloned T cell lines. I. Interactions between cloned amplifier and cytolytic T cell lines. J Exp Med (1980) 3.00
Nucleotide sequence of a streptomycete aminoglycoside phosphotransferase gene and its relationship to phosphotransferases encoded by resistance plasmids. Proc Natl Acad Sci U S A (1983) 2.87
Major histocompatibility complex-linked specificity of gamma delta receptor-bearing T lymphocytes. Nature (1987) 2.81
Characterization of CTLA-4 structure and expression on human T cells. J Immunol (1993) 2.68
Blocked Ras activation in anergic CD4+ T cells. Science (1996) 2.64
The nature of major histocompatibility complex recognition by gamma delta T cells. Cell (1994) 2.64
Primary sequence of the alpha-toxin gene from Staphylococcus aureus wood 46. Infect Immun (1984) 2.60
Acute graft-versus-host reaction can be aborted by blockade of costimulatory molecules. J Immunol (1995) 2.52
B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity (1995) 2.45
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40
Absence of B7-dependent responses in CD28-deficient mice. Immunity (1994) 2.32
The rate of division of antibody-forming cells during the early primary immune response. J Exp Med (1968) 2.10
CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity (1996) 2.09
Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev (1989) 2.08
The complexities of T-cell co-stimulation: CD28 and beyond. Immunol Rev (1996) 2.08
In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol (2005) 2.07
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant (2010) 2.06
Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A (1993) 2.03
Self-reactive gamma delta T cells are eliminated in the thymus. Nature (1990) 2.02
CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J Immunol (1998) 2.01
Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med (1985) 2.00
Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Nature (1985) 2.00
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity (1995) 1.97
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J Exp Med (1997) 1.96
Differential expression of two distinct T-cell receptors during thymocyte development. Nature (1987) 1.95
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol (1992) 1.91
Listening and note taking. J Educ Psychol (1972) 1.91
In vitro characterization of five humanized OKT3 effector function variant antibodies. Cell Immunol (2000) 1.84
Evidence implicating utilization of different T cell receptor-associated signaling pathways by TH1 and TH2 clones. J Immunol (1990) 1.84
Characterization of murine thymocytes with CD3-associated T-cell receptor structures. Nature (1987) 1.83
T-cell lines which cooperate in generation of specific cytolytic activity. Nature (1979) 1.82
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation (1995) 1.82
Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature (1974) 1.81
CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A (1995) 1.80
Murine T lymphocyte clones with distinct immunological functions. Immunol Rev (1981) 1.79
Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes. J Immunol (1982) 1.78
CD28 costimulation promotes the production of Th2 cytokines. J Immunol (1997) 1.78
Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor. Cell (1988) 1.77
T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J Exp Med (1997) 1.77
Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. J Immunol (2000) 1.76
Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody. Diabetes (1992) 1.74
Rejection of renal allografts: specific immunologic suppression. Science (1968) 1.73
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med (2001) 1.70
Specific suppression of immune responses. Science (1973) 1.67
Monoclonal antibodies to estrophilin: probes for the study of estrogen receptors. Proc Natl Acad Sci U S A (1980) 1.66
Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J Immunol (1988) 1.63
Monoclonal antibody to L3T4 blocks the function of T cells specific for class 2 major histocompatibility complex antigens. J Immunol (1984) 1.62
Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies. J Immunol (1985) 1.62
Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J Immunol (1994) 1.61
Extrathymic selection of TCR gamma delta + T cells by class II major histocompatibility complex molecules. Cell (1990) 1.61
"Anergy" of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J Exp Med (1994) 1.60
Anti-idiotypic antibody in rat transplantation immunity. I. Production of anti-idiotypic antibody in animals repeatedly immunized with alloantigens. J Immunol (1974) 1.59
Novel function for intestinal intraepithelial lymphocytes. Murine CD3+, gamma/delta TCR+ T cells produce IFN-gamma and IL-5. J Immunol (1991) 1.58
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am J Transplant (2007) 1.57
Cellular deficit in thymectomized mice. Nature (1970) 1.57
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol (1997) 1.55
Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature (1989) 1.54
Properties of rat anti-MHC antibodies produced by cloned rat-mouse hybridomas. Immunol Rev (1979) 1.54
Anti-CD3 antibody for autoimmune disease, a cautionary note. Lancet (1989) 1.51
Differential function of intestinal intraepithelial lymphocyte subsets. J Immunol (1992) 1.51
Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J Immunol (1989) 1.51
Structure and specificity of a class II MHC alloreactive gamma delta T cell receptor heterodimer. Science (1989) 1.50